University of Nevada, Reno
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Nevada, Reno sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).
University of Nevada, Reno: 23 sponsored US clinical trials, 2 recruiting.
University of Nevada, Reno sponsors 23 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 18 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Wellness Program, with 1 trials.
Top-decile sponsor footprint
University of Nevada, Reno ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
23 total, page 1 of 1
The Social Regulation of Threat-related Vigilance and Arousal
NCT05558527
Reducing Mental Health Disparities Among Latinxs With a Telenovela Intervention
NCT06163599
The Counselor Led Resident Wellness Study
NCT07053111
Gathering Evidence on Best Practices for Lay Rescuer CPR Training
NCT05908500
Feasibility and Acceptability of Switching to E-cigarettes Among Cigarette Smokers Engaged in SUD Treatment
NCT05918887
Characterizing Protein Biomarkers of Post-infection Irritable Bowel Syndrome
NCT06032117
Clinical Research Study of the Benefits of BREG Polar Care Wave to Reduce Opioid Use by Patients Having Undergone Arthroscopic Rotator Cuff Repair Shoulder Surgery
NCT07455474
"Natural" and "Organic" Cigarette Descriptors: Association With Expectancies, Subjective Effects, Topography, and Biomarkers of Exposure Among Daily Smokers
NCT05468333
Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients
NCT05086185
Single Session Intervention to Prevent Common Mental Disorders and Among College Students
NCT04267068
Acceptability of Self-Led Mindfulness-Based Intervention
NCT05115175
Augmenting Exposure Therapy for Social Anxiety With Transcranial Direct Current Stimulation
NCT03743571
Use of Safety Behaviors in Exposure Therapy for Arachnophobia
NCT04470882
¡Yo no Estoy Loc@! Improving Treatment Engagement for Latinos Using an E-E Video
NCT03889301
Growth Mindset Psychoeducation for Modifiable Risk Factors for CMD
NCT03707522
Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics
NCT03466502
Assessing the Mechanism of Change of Functional Analytic Psychotherapy
NCT03562962
Evaluation of Oral Simethicone With Low Volume Polyethylene Glycol Bowel Preparation During Colonoscopy
NCT03410524
"SVEAT" Chest Pain Scoring System
NCT03511430
Developing Adaptive Interventions for Suicidal College Students Seeking Treatment - SMART
NCT02442869
Linagliptin and Mesenchymal Stem Cells: A Pilot Study
NCT02442817
Impact of Periodontal Disease on Outcomes in Diabetes
NCT02289066
Community Engaged Colon Cancer Screening Patient Navigator Program
NCT03031171
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 2 |
Where University of Nevada, Reno enrollment is open (later-stage tilt)
2 recruiting of 23 indexed (9% open); 18 completed (78%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Wellness Program (1 trial), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Nevada, Reno: open-pipeline peers nationwide
Peers matched on 23 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
University of Nevada, Reno sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 23 trials (± recruiting share)
- AMAG Pharmaceuticals · 23 trials · 9% recruiting
- AtriCure · 23 trials · 22% recruiting
- Cara Therapeutics · 23 trials · 0% recruiting
- Craig L Slingluff, Jr · 23 trials · 4% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Iowa State University · 9% recruiting · 23 trials
- New Approaches to Neuroblastoma Therapy Consortium · 9% recruiting · 23 trials
- Rhythm Pharmaceuticals · 9% recruiting · 23 trials
- Swedish Orphan Biovitrum · 9% recruiting · 23 trials
Related
What to do with this University of Nevada, Reno page
23 registered trials is a research-attention snapshot, not an endorsement of University of Nevada, Reno or any single study.
- 2 of University of Nevada, Reno's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Wellness Program is the condition University of Nevada, Reno studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Wellness Program trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Nevada, Reno pipeline card: 23 registered trials from official public datasets.Report a data error.